Shin Nippon Biomedical Lab.Ltd Registered Shares o.N.

Sector and Industry

Healthcare, Healthcare Services

Performance (1Y)

11.61%

Market Cap

-

P/E Ratio

12.89

Dividend Yield

3.54 %

Earnings per Share

0.63 €

Peer Group

Company NameMarket CapRevenue Last Reported YearP/E RatioProfit Growth 1YLast PricePrevious Trading Day Change
UnitedHealth Group Inc.254.66 Bil.396.73 Bil.24.94
-19.75 %
0.00
-
Thermo Fisher Scientific Inc.185.62 Bil.39.50 Bil.32.67
+1.45 %
0.00
-
Danaher Corp.137.79 Bil.21.78 Bil.45.36
-11.47 %
0.00
-
McKesson Corporation90.13 Bil.348.09 Bil.22.55
+33.83 %
0.00
-
HCA Healthcare Inc.89.28 Bil.67.01 Bil.16.48
+12.93 %
0.00
-
Elevance Health Inc.65.88 Bil.176.51 Bil.13.91
-9.22 %
0.00
-
The Cigna Group61.74 Bil.243.65 Bil.12.41
+66.33 %
0.00
-
Cencora Inc.51.58 Bil.291.15 Bil.39.26
+1.16 %
0.00
-
IDEXX Laboratories Inc.45.92 Bil.3.81 Bil.51.74
+14.41 %
0.00
-
Zoetis Inc.45.52 Bil.8.39 Bil.20.89
+3.10 %
0.00
-

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE6.9 G0 Units
PRICE DETERMINATION TIME07/21/2026 / 07:02:07 PM
DAILY VOLUME (UNITS)0
DAILY HIGH / LOW76.9
PREV. DAY'S PRICE6.85 (07/20)
CHANGE DAY BEFORE
+0.05
0.73 %
52 WEEK HIGH / LOW10.6 (12/11)5.7 (06/09)

Key Figures (in EUR)

2023202420252026e2027e
EARNINGS PER SHARE
0.850.720.630.510.52
DIVIDENDS PER SHARE
0.320.310.290.270.27
DIVIDEND YIELD IN %
3.29 %3.49 %3.54 %--
DIVIDEND GROWTH IN %
-10.18 %-4.28 %-6.30 %--
PRICE - EARNINGS RATIO
11.4312.1012.8913.4813.29
PRICE - BOOK RATIO
1.851.491.37--
PRICE - SALES RATIO
2.391.841.81--
PRICE - CASH FLOW RATIO
30.008.477.07--
Further Key Figures

Master Data

WKN
A0BMJN
ISIN
JP3379950003
SYMBOL
YB3
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Equity
DENOMINATION
Shin Nippon Biomedical Laboratories
INDEX MEMBERSHIP
-
TRADING SEGMENT
-
TRADING HOURS
07:30:00 AM - 10:00:00 PM
TRADING CURRENCY
Euro
NOMINAL CURRENCY
-
SETTLEMENT CURRENCY
Euro
SECTOR AND INDUSTRYHealthcare, Healthcare Services
NUMBER OF SHARES
-
MARKET CAPITALISATION
-

Performance overview

1W1M3M6M1Y3Y5YYTD
PERFORMANCE
-2.84 %
18.10 %
-13.84 %
-20.35 %
-11.61 %
-46.06 %
-13.84 %
-23.89 %
HIGH7.107.108.059.6010.6015.3021.609.60
LOW6.805.805.705.705.705.705.705.70

Dividende

pro Aktie

Company profile

Shin Nippon Biomedical Laboratories, Ltd. is a contract research organization providing drug development services including safety research, clinical pharmacology, and clinical trials. Its operations are carried out through the following segments: CRO Business, Translational Research Business, Medipolis Business, and Others. he CRO business is a business that verifies the efficacy and safety of test substances created by clients such as pharmaceutical companies using laboratory animals, cells, and bacteria. The Translational Research Business segment utilizes drug and device development capabilities to accelerate drug development which leads to out-licensing to pharmaceutical companies. The Medipolis Business segment deals with the property management and geothermal power generation businesses. The Others segment engages in the information collection in Europe, which includes real estate and environmental equipment operations. The company was founded in April 1957 and is headquartered in Tokyo, Japan.

Shareholder Structure (Top 10)

AnteilName
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available

Analyst Rating

Ø-Target Price DistanceNot Available
Current Price
Not Available
Ø-Target Price
Not Available
Average ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0

Company Events

No company events available.